What's Happening?
Oklo, a nuclear reactor developer, is not expected to book its first commercial power revenue before 2028, according to an analysis of the company's own published schedule. While Oklo recently reported its first revenue, approximately $1.2 million from
services, and achieved 'first criticality' at its Groves isotope test reactor in Lockhart, Texas, these milestones do not translate to immediate commercial power generation. The company's primary product, electricity sold from its Aurora powerhouses, is still in development. The timeline for the Aurora-INL plant, the first powerhouse at Idaho National Laboratory, began with groundbreaking in September 2025. Oklo's initial projection for commercial operation was late 2027 or early 2028, which has since firmed to an 'ambitious target of deploying our first powerhouse in 2028.' This schedule involves five regulatory steps with the Department of Energy, three of which are still pending, along with fuel fabrication, loading, and start-up testing. The first core requires a Department of Energy award of high-assay low-enriched uranium (HALEU), which Oklo must fabricate at a new facility.
Why It's Important?
The projected 2028 timeline for Oklo's commercial power revenue is significant for investors and the broader energy sector. While the company has demonstrated progress with its test reactor and secured substantial cash reserves ($3 billion as of June), the delay in commercial power generation means that the growth stock's valuation is heavily reliant on future performance rather than immediate returns. The nuclear energy industry is characterized by long development cycles and stringent regulatory processes, making Oklo's 'ambitious' target of three years from groundbreaking to commercial operation a notable, albeit challenging, goal. The reliance on a one-time government allocation of HALEU for the first plant, as opposed to the commercial supply from Centrus Energy expected in 2029 for later powerhouses, highlights the complexities and dependencies in bringing advanced nuclear technology to market. This situation underscores the inherent risks and long-term investment horizons associated with innovative energy solutions, particularly those in the nuclear sector.
What's Next?
Oklo's immediate focus will be on progressing through the remaining three regulatory steps with the Department of Energy for its Aurora-INL plant. This includes securing the necessary approvals, fabricating the high-assay low-enriched uranium (HALEU) fuel at its new Idaho facility, and completing the construction, fuel loading, and start-up testing phases. While commercial power revenue is not anticipated before 2028, the company expects to generate revenue from its isotope business, particularly from the NRC-licensed Idaho Radiochemistry Laboratory, in the first part of 2027. The Groves test reactor is also expected to produce research-and-development quantities of isotopes over the next year. Investors and stakeholders will be closely watching for updates on these milestones, as they represent critical steps towards the eventual commercialization of Oklo's power generation technology. The company's ability to meet its ambitious 2028 target will depend on efficient regulatory navigation and successful execution of its construction and operational plans.
Beyond the Headlines
Oklo's journey reflects the broader challenges and opportunities in the development of advanced nuclear energy technologies. The company's model of building, owning, and operating its plants and selling electricity directly positions it as a potential disruptor in the energy market, especially given the increasing demand for reliable, carbon-free power from sectors like artificial intelligence data centers. The agreement with Meta Platforms to support future development underscores the growing interest from major corporations in securing long-term, sustainable energy sources. However, the regulatory hurdles and the need for specialized fuel like HALEU highlight the significant infrastructure and policy support required for such innovations to scale. The distinction between a test reactor and a commercial power plant also emphasizes the leap from proof-of-concept to market-ready solutions, a common challenge for cutting-edge technologies. Oklo's progress will be a key indicator of the viability and timeline for next-generation nuclear power in the U.S. energy landscape.
